You are here:
NICE
NICE Guidance
Conditions and diseases
Cancer
Colorectal cancer
Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer
Technology appraisal guidance
Reference number:
TA118
Published:
24 January 2007
Last updated:
01 January 2012
Guidance
Tools and resources
Information for the public
Evidence
History
Research recommendations coming out of this guidance
There are no research recommendations for TA118